Diabetes Clinical Trials in Indiana

37 recruiting studies across 1 city

Browse by City

All Trials in Indiana

Phase

Trial	Phase	Sponsor	Dist.
Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years	N/A	Case Western Reserve University	<1 mi
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)	Phase 3	Eli Lilly and Company	<1 mi
Mechanisms Underlying Impaired Diabetic Wound Healing	—	University of Pittsburgh	<1 mi
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes	N/A	Medtronic Diabetes	<1 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)	Phase 1/2	COUR Pharmaceutical Development Company, Inc.	<1 mi
Type 1 Diabetes Extension Study	—	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes	Phase 2	SAb Biotherapeutics, Inc.	<1 mi
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes	N/A	Indiana University	<1 mi
TrialNet Pathway to Prevention of T1D	—	University of South Florida	<1 mi
Denosumab for Type 1 Diabetes	Phase 1/2	City of Hope Medical Center	<1 mi
Drug Interaction Potential of Pro-Inflammatory Conditions	—	Indiana University	<1 mi
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes	Phase 3	Novo Nordisk A/S	<1 mi
CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis	N/A	Indiana University	<1 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes	Phase 2	Zucara Therapeutics Inc.	<1 mi
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial	N/A	Indiana University	<1 mi
Registry for Stage 2 Type 1 Diabetes	—	Sanofi	<1 mi
Rare and Atypical Diabetes Network	—	University of South Florida	<1 mi
To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.	N/A	Viral N. Shah	<1 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms	—	Milton S. Hershey Medical Center	<1 mi
CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations	N/A	Capsicure, LLC	<1 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes	Phase 3	Eli Lilly and Company	<1 mi
Fenofibrate for Prevention of DR Worsening	Phase 3	Jaeb Center for Health Research	<1 mi
Biomarker of Diabetic Retinopathy	—	Indiana University	<1 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)	Phase 3	Eli Lilly and Company	<1 mi
Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events	N/A	Indiana University	<1 mi
T1D Pregnancy & Me	—	Jaeb Center for Health Research	<1 mi
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action	Phase 2	Heba M. Ismail	<1 mi
Bionic Pancreas in CFRD	Phase 3	Jaeb Center for Health Research	<1 mi
TArgeting Type 1 Diabetes Using POLyamines (TADPOL)	Phase 2	Emily K. Sims	<1 mi
Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics	—	Milton S. Hershey Medical Center	<1 mi
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes	N/A	Indiana University	<1 mi
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)	Phase 3	Viking Therapeutics, Inc.	<1 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	13 mi
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide	Phase 2	Eli Lilly and Company	14 mi
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)	—	M.D. Anderson Cancer Center	15 mi
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease	Phase 3	Prokidney	15 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.